The role of STATs in transcriptional control and their impact on cellular function
By Jacqueline F. Bromberg, James E. Darnell. Oncogene, 2000
1,308 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/20e1b40872853d80e55d40d239d49aadaf0b3895
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Jacqueline F. Bromberg
- R. Jove
- T. Hirano
- Hua Yu
- L. Ellis
- Eric B. Haura
- Alexander Levitzki
- Lanxi Song
In Oncology
In Pathology and Forensic Medicine
Citations in the corpus
- Stat proteins and oncogenesis. (2002, background): “Since that time a large number of growth factor receptors and some nonreceptor tyrosine kinases have been found to lead to the activation of these transcription factors (2).”
- IL-6 in inflammation, autoimmunity and cancer (2020, background): “Activated JAK phos-phorylates tyrosine residues in the cytoplasmic domain of gp130 (30, 31, 61, 62, 102, 103).”
- STAT proteins: From normal control of cellular events to tumorigenesis (2003, background): “The STATs have an SH2 domain through which they make contact with the receptor, dimerize and move into the nucleus (Bromberg and Darnell, 2000) (Fig.”
- Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. (2002, background): “specific promoter sequences and induce gene expression (2, 6).”
- Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells (2001, background): “Moreover, constitutively-activated STAT mutants have been shown to alter cellular growth control and directly induce cellular transformation (Ariyoshi et al., 2000; Bromberg et al., 1999; Bromberg and Darnell, 2000; Demoulin et al., 2000).”